Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Shubhshree Bio.
Quarter-by-quarter operating performance
Financials of Shubhshree Bio.
Annual income statement trend
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales + | 163 | 202 |
| Expenses + | 152 | 187 |
| Operating Profit | 11 | 15 |
| OPM % | 7% | 7% |
| Other Income + | 1 | 1 |
| Interest | 0 | 1 |
| Depreciation | 0 | 0 |
| Profit before tax | 11 | 14 |
| Tax % | 24% | 21% |
| Net Profit + | 8 | 11 |
| EPS in Rs | 15.43 | 20.09 |
| Dividend Payout % | 0% | 0% |
Financials of Shubhshree Bio.
Capital structure and asset base
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 5 | 5 |
| Reserves | 25 | 36 |
| Borrowings + | 8 | 13 |
| Other Liabilities + | 12 | 16 |
| Total Liabilities | 51 | 70 |
| Fixed Assets + | 3 | 6 |
| CWIP | 0 | 0 |
| Investments | 5 | 1 |
| Other Assets + | 42 | 63 |
| Total Assets | 51 | 70 |
Financials of Shubhshree Bio.
Operating, investing and financing cash movement
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity + | -9 | |
| Cash from Investing Activity + | -6 | |
| Cash from Financing Activity + | 22 | |
| Net Cash Flow | 8 | |
| Free Cash Flow | -11 | |
| CFO/OP | -58% |
Financials of Shubhshree Bio.
Working capital efficiency and return ratios
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 59 | 69 |
| Inventory Days | 12 | 17 |
| Days Payable | 32 | 27 |
| Cash Conversion Cycle | 39 | 59 |
| Working Capital Days | 28 | 40 |
| ROCE % | 33% |
PAT growth seen with recent quarters growing by ~85% YoY, indicating strong earnings momentum. Key concall takeaways from Rathi Steel & Power Ltd's Q1 FY27…
SKP is steadily increasing capacity from about 80-100 tons earlier to around 1,800 tons now, operating at ~80% utilization (Page 20). Key concall takeaways…
Q1 FY27 showed strong profitability with EBITDA margin improving to 16.29% and net profit margin to 9.18%. Key concall takeaways from Mitsu Chem Plast Ltd's Q1…
Current capacity expansion planned for 300-350 crores revenue, further growth through organic or inorganic expansion. Key concall takeaways from Simplex…